Biomimetic Catalase‐Templated Nanoprobes for MRI‐Guided Oxygen‐Supplemented Photodynamic Therapy in Breast Cancer
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202502430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Wen Gu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China. Hauptthemen laut MEDLINE: Photochemotherapy, Catalase, Magnetic Resonance Imaging, Oxygen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Project.
Abstract (Originalsprache)
Photodynamic therapy (PDT) faces critical challenges in practical application due to tumor hypoxia and the lack of precise imaging guidance. To address these limitations, we engineered Gd@CAT Ce6 (GCC) via catalase (CAT)‐mediated biomimetic synthesis, where CAT serves as a structural template for the green synthesis of gadolinium‐based nanoparticles, an enzymatic oxygenator through H 2 O 2 decomposition, and a hydrophobic host for photosensitizer chlorin e6 (Ce6) loading. GCC leverages CAT's enzymatic activity to decompose tumor‐overexpressed H 2 O 2 into oxygen, effectively mitigating hypoxia while amplifying Ce6‐mediated reactive oxygen species (ROS) generation under laser irradiation. In vitro studies confirmed a uniform nanostructure (approximately 10 nm), high longitudinal relaxivity (r 1 = 10.9 m m −1 s −1 ), and potent ROS production. In vivo magnetic resonance imaging (MRI) demonstrated significant tumor accumulation via the enhanced permeability and retention (EPR) effect, extending the imaging window to 1–2 h for precise therapy guidance. Notably, GCC combined with laser irradiation suppressed 4T1 tumor growth by 87.84% in mice, outperforming controls, while exhibiting good biocompatibility in blood and organ toxicity assays. This work presents an enzyme‐based theranostic strategy that synergizes real‐time imaging with self‐oxygenating PDT, offering a promising solution to overcome hypoxia‐driven therapeutic resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
- Department of Radiology, Changzheng Hospital, Second Military Medical University, Shanghai, China.
- Department of Radiology, Shanghai Frontiers Science Center of Nanocatalytic Medicine, The Institute for Biomedical Engineering & Nano Science, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
- Shanghai Research Institute for Intelligent Autonomous Systems, Tongji University, Shanghai, China.
ORCID-Profile: Bingbo Zhang
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Project
Zitieren
APA
Gu, W., Liu, D., Wu, Y., Yang, W., Yun, Y., Zhang, B., & Liu, S. (2026). Biomimetic Catalase‐Templated Nanoprobes for MRI‐Guided Oxygen‐Supplemented Photodynamic Therapy in Breast Cancer. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202502430
Vancouver
Gu W, Liu D, Wu Y, Yang W, Yun Y, Zhang B, et al. Biomimetic Catalase‐Templated Nanoprobes for MRI‐Guided Oxygen‐Supplemented Photodynamic Therapy in Breast Cancer. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202502430
BibTeX
@article{Gu2026,
author = {Gu, Wen and Liu, Dinghua and Wu, Yanyan and Yang, Weitao and Yun, Yanjing and Zhang, Bingbo and Liu, Shiyuan},
title = {Biomimetic Catalase‐Templated Nanoprobes for MRI‐Guided Oxygen‐Supplemented Photodynamic Therapy in Breast Cancer},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202502430}
}
EUVIMED